Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome is a research paper published in Acta Pharmaceutica Sinica B (2022). On theSindex it has a DataRank of 0. It has been cited 54 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA257961
National Institutes of Health
Grant: R01EB019036
National Institutes of Health
Grant: U01CA207946
Ohio State University
Grant: P30CA016058
National Institutes of Health
Grant: 3P30CA016058-15S1
CORE--HORMONE RECEPTOR LABORATORY
National Institutes of Health
Grant: 1R01EB019036-01
Cancer specific and organ-avoiding RNA architectures for quantitative imaging
National Institutes of Health
Grant: 5R01CA257961-05
TNBC Ligand-displaying Exosomes Using RNA Nanotechnology for Targeted Cytosol Delivery of RNAi without Endosome Entrapment
National Institutes of Health
Grant: 5U01CA207946-02
Optimizing RNA nanoparticles size and shape for enhancing cancer targeting and treatment
National Cancer Institute
FWCI
3.61
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals